Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways
Jay C. Jha(Monash University), Karin Jandeleit‐Dahm(Deutsches Diabetes-Zentrum e.V.)
Cited by 55
Related Papers
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
|Kidney International|2023|121
Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions
|Biomedicines|2024|103
Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis
|Journal of Clinical Investigation|2018|83
Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation
|Handbook of experimental pharmacology|2020|62